Skip to search formSkip to main contentSkip to account menu

Amphotericin B Colloidal Dispersion

Known as: AMPHOTERICIN B CHOLESTERYL SULFATE, Amphotericin B Colloidal Dispersion [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Because of the increasing prevalence and changing microbiological spectrum of invasive fungal infections, some form of… 
2006
2006
BACKGROUND In Bihar, India, where visceral leishmaniasis (VL) is hyperendemic and refractory to antimony, amphotericin B is the… 
Review
2001
Review
2001
Abstract The aim of this study was to review the characteristics and outcome of 21 patients with invasive mucormycosis treated… 
Review
1999
Review
1999
The efficacy and safety of Amphotericin B Colloidal Dispersion (ABCD) have been investigated on 572 patients in five Phase I/II… 
Highly Cited
1998
Highly Cited
1998
We conducted a prospective, randomized, double-blind study comparing amphotericin B colloidal dispersion (ABCD) with amphotericin… 
Highly Cited
1998
Highly Cited
1998
ABSTRACT Studies with animals and in vitro studies have demonstrated that flucytosine plus amphotericin B or fluconazole has… 
Highly Cited
1997
Highly Cited
1997
To assess the efficacy and safety of amphotericin B colloidal dispersion (ABCD), 82 patients with proven or probable… 
Highly Cited
1995
Highly Cited
1995
Amphotericin B colloidal dispersion (ABCD), a novel formulation of amphotericin B and cholesteryl sulfate in a 1:1 ratio, was… 
Highly Cited
1994
Highly Cited
1994
We investigated the safety and efficacy of amphotericin B colloidal dispersion (ABCD) for the treatment of invasive pulmonary… 
Review
1992
Review
1992
SummaryAmphotericin B remains a very important drug for the treatment of fungal infections despite its toxicity. Encapsulation of…